Shanghai, China, September 07, 2026 --(PR.com)-- Driven by rapid development in global biopharma, pharma firms, laboratories, CRO/CDMOs and IVD manufacturers are confronted with fragmented supply networks, scattered supplier resources, complicated cross‑border compliance barriers, unstable product quality, variable batch bioactivity and extended procurement lead‑times.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Nick Li
Kepon Biotech Launches Integrated Cross‑Border Risk‑Control Solutions for Global Cell Culture Media Trade
Shanghai, China, August 19, 2026 --(PR.com)-- Cell culture media — including basal powder media, complete media, serum‑free GMP‑grade clinical media and microbial fermentation media — serve as core biomaterials for cell therapy, in‑vitro diagnostics, biopharmaceutical production and life‑science research. Rich in active proteins, growth factors and vitamins, these products are highly vulnerable to temperature shifts, light exposure and freeze‑thaw cycles.
Kepon Biotech Launches Integrated Cross‑Border Solutions for Global Spermidine Procurement
Shanghai, China, August 19, 2026 --(PR.com)-- Spermidine and Spermidine Trihydrochloride are high‑value biochemical raw materials widely used in functional food, pharmaceutical API synthesis, anti‑aging cosmetics and life‑science research. Nevertheless, global cross‑border trade faces major obstacles: disparate regional compliance regulations, grade‑specific customs declaration standards, and inherent product vulnerabilities including strong hygroscopicity and oxidation susceptibility.
Kepon Biotech Launches One-Stop Cross-Border Compliance & Logistics Solutions for Life Science Reagents
Shanghai, China, August 19, 2026 --(PR.com)-- Surging global demand for laboratory biological reagents and certified reference standards creates persistent cross‑border procurement challenges. International buyers struggle with cumbersome special‑goods customs approvals, unreliable cold‑chain performance, fragmented regional regulatory frameworks, inflexible high minimum‑order quantities, and disjointed supplier networks, which hurt procurement efficiency and introduce substantial trade risks.
Kepon Biotech Launches Integrated Cross‑Border Export Solutions for Global LAL Endotoxin‑Testing Reagent Procurement
Shanghai, China, August 18, 2026 --(PR.com)-- Stricter global pharmacopoeia standards including USP <85>, EP 2.6.14 and EAEU TR‑CU make Limulus Amebocyte Lysate (LAL) critical for bacterial endotoxin testing in biopharma manufacturing, vaccine R&D, medical‑device QC and cell‑therapy labs. Rising worldwide demand for reliable LAL kits leaves buyers across Russia‑CIS, Southeast Asia, the Middle East, EU and North America facing frequent cross‑border supply‑chain obstacles.
Kepon Biotech Unveils Full-Link Risk Control & Compliance Solutions for Global Cell Culture Media Trade
Shanghai, China, August 18, 2026 --(PR.com)-- Booming global investment in cell therapy, vaccine development, monoclonal antibody research and IVD manufacturing has positioned cell culture media as an indispensable core consumable for life‑science labs. Still, cross‑border buyers frequently face hidden losses stemming from unqualified vendors, fragmented logistics and unfamiliar regional regulatory rules.
Shanghai Kepon Biotech Launches Full Risk-Control Cross-Border Solutions for Certified Reference Standards Procurement
Shanghai, China, August 17, 2026 --(PR.com)-- Global demand for certified reference standards continues to surge across biopharmaceutical R&D, food safety inspection and environmental monitoring industries. As critical calibration and testing materials, qualified reference standards determine the accuracy of laboratory data and official inspection results.
Food Safety Standards Raw Material Procurement Solutions & Risk Avoidance Guide Released by Shanghai Kepon Biotech for Global Food Testing & Food Manufacturing Plants
Shanghai, China, August 16, 2026 --(PR.com)-- Stricter global food supervision drives rising demand for certified food safety reference standards and testing reagents. Cross-border buyers frequently face invalid test data, customs detention and failed official audits due to unqualified suppliers, fragmented compliance support and improper temperature-controlled transit.
Same rules, smarter tools: what the TGA’s AI guidance means for AI and medical devices
Managing regulatory risk for adaptive and evolving AI systems in healthcare 5 min read AI adoption in healthcare is accelerating, with tools now influencing everything from administrative efficiency to clinical decision making. The Therapeutic Goods Administration (TGA) has updated its guidance to clarify how existing medical device regulations apply to AI-enabled technologies.
Australia revises renewable energy forecasts for wind and transmissions
The announcement came as the Australian Energy Market Operator (AEMO) released a draft of its highly anticipated 2026 Integrated System Plan (ISP), in which it radically scaled back previous forecasts for wind generation and transmission line capacity. Previously AEMO forecast that wind generation capacity should reach 42.6GW by the end of the decade. This has now been revised down to 26GW by 2030, 40GW by 2035 and 57GW by 2050.
Queensland energy roadmap uncovers coal hard truths
The Queensland energy roadmap, released by the Crisafulli state government on 10 October, focuses on growing the economy and attracting private sector investment to meet Queensland’s infrastructure needs. Commitments made by the state government in the document include: investing A$1.6 billion (approx.
Biomimetic models in radiotherapy research: An essential bridge between bench and beam
Get full text access Log in, subscribe or purchase for full access. References 1. Borras, J.M. ∙ Lievens, Y. ∙ Dunscombe, P. ... The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis Radiother. Oncol. 2015; 116:38-44 2. Puck, T.T. ∙ Marcus, P.I. Action of x-rays on mammalian cells J. Exp. Med. 1956; 103:653-666 3. Kinker, G.S. ∙ Greenwald, A.C. ∙ Tal, R. ... Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity Nat.
ALTAR - Autocomplete for your mind | Product Hunt
Home Product ALTAR Autocomplete for your mind ALTAR is an AI-powered workspace that organizes everything you save—notes, images, links—into a smart knowledge base. It learns what matters to you and helps you create, analyze, and find insights in seconds, helping you turn ideas into action without friction Free Launch tags: Design Tools•Productivity•Artificial Intelligence About this launch ALTAR Auto-complete for your mind.
InIP: What's happening in intellectual property - February 2024
Your regular wrap-up of some of the world's leading and intriguing IP stories 10 min read By Ioana Sabau In June 2023, we reported on a ruling by the Federal Court of Australia that clarified how courts may evaluate deceptive similarity following the High Court's decision in Self Care IP Holdings v Allergan Australia Pty Ltd [2023] HCA 8 (Self Care).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Nick
Contact Nick, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack